Jump to content
RemedySpot.com

XMRV & CFS –It’s not the end

Rate this topic


Recommended Posts

Posted

http://bit.ly/ez3uMb

virology blog

ABOUT VIRUSES AND VIRAL DISEASE

By Racaniello

A virology Professor unravels viruses

Questions? virology@...

XMRV and CFS –

It's not the end

22 December 2010

Yesterday the Chicago Tribune [http://bit.ly/ghRAam]

published my reaction to the four papers on the

retrovirus XMRV published this week in the journal

Retrovirology [http://bit.ly/fwezz3].

I was quoted as saying " These four papers are

probably the beginning of the end of XMRV and

CFS " .

I wish to retract this statement and

explain my reasons for doing so.

Early Monday a reporter for the Chicago Tribune,

Trine Tsouderos, sent an email asking for my

thoughts on four XMRV papers that had just been

released ( paper one [http://bit.ly/eo6e60], two

[http://bit.ly/gJrkSn], three[http://bit.ly/eZCYpq],

four[http://bit.ly/h1sz1q] ).

I read all four papers and decided that they raised

serious concerns about the role of XMRV in human

disease.

Specifically, the four papers demonstrated different

ways that assays for XMRV could be subject to

contamination with murine viral sequences.

I wrote an email to Ms. Tsouderos outlining my

summary of the papers, and later that day her article

was published. My statement was reproduced exactly

from the email I had sent her, so I was not

misquoted.

I then set out to write about the papers for my blog

about viruses [http://bit.ly/e0vDyl]. I read the

papers over again, and began checking XMRV

sequences in Genbank [http://bit.ly/edxPIh].

I also began an email correspondence with authors

of three of the four papers, and spoke with my

virology colleagues here at Columbia.

As a consequence of this additional research I

decided that my initial impression of the papers was

incorrect, which is evident in my post entitled 'Is

XMRV a laboratory contaminant?'

[http://bit.ly/edNVpq].

Almost immediately after publishing the piece

readers began to ask why my comments to the

Chicago Tribune had such a different tone.

I concluded that a retraction and explanation were

necessary.

Upon re-reading three of the four Retrovirology

papers it became clear to me that they show that

identification of XMRV can be fraught with

contamination problems, but they do not imply that

previously published studies are compromised by

these findings.

Clearly any new studies done on XMRV should keep

in mind the potential for contamination from PCR kits

and murine nucleic acids.

I was initially more troubled by the fourth paper by

Hue and colleagues [http://bit.ly/eo6e60].

There are four major findings in this paper (gag PCR

primers are not specific for XMRV; the virus is

present in 5 human tumor cell lines; two XMRV

isolates are nearly identical to a virus from the

human prostate cell line and also contain an

insertion from the murine retrovirus MoMLV; and

there is more nucleotide diversity in viral sequences

from 22Rv1 cells than in all the patient XMRV

sequences).

The fact that two XMRV isolates seem to be

laboratory contaminants – judged by the presence of

MoMLV sequences – was initially unsettling until it

became clear that other XMRV isolates do not have

this insertion.

That leaves the fourth finding – that XMRV from

22Rv1 cells appears ancestral to, and more diverse

than, all the human XMRV sequences.

I decided that this result was less troublesome than

I had originally believed, in part because it is not

clear that the differences among the 22Rv1 viruses

did not arise during PCR amplification.

In other words, these four papers are NOT the

beginning of the end of XMRV and CFS. Rather,

research on the role of this virus in human disease

must proceed, with large, case-controlled

epidemiological studies, as suggested by others

[http://bit.ly/fMZ6xx].

I would like to apologize to anyone who was

offended, angered, or disappointed in any way by my

statement to the Chicago Tribune. It is my goal to

educate the public about virology, and clearly I did

not do that very well.

There are at least two lessons that you can take

away from this incident. First, that I make mistakes,

and that I'm willing to admit it. Everyone does,

including scientists. Second, if I had difficulties

interpreting these papers, how would non-scientists

fare?

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...